These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 105256)

  • 1. [Clofibrate prevention study by WHO. Results and consequences].
    MMW Munch Med Wochenschr; 1979 Jan; 121(2):45-6. PubMed ID: 105256
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decision of the Department of Drugs of the National Board of Health and Welfare: indications for the use of clofibrate will be limited].
    Strandberg K
    Lakartidningen; 1979 May; 76(18):1718-9. PubMed ID: 449462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of Clofibrate Spofa in the prevention of ischemic heart disease].
    Geizerová H; Grafnetter D; Hejl Z
    Cas Lek Cesk; 1972 Jun; 111(20):466-9. PubMed ID: 5046003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clofibrate--more harm than good?].
    Huttunen J
    Duodecim; 1979; 95(3):97-9. PubMed ID: 761565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study].
    Geizerová H; Gyarfas I; Lamm G; Oliver M; Heady JA; Morris JN; Green K; Strasser T; Fejfar Z
    Cas Lek Cesk; 1979 Apr; 118(15):449-53. PubMed ID: 455361
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of ischaemic heart disease. Possibilities and problems.
    Fejfar Z; Vanĕcek R
    Rev Czech Med; 1970; 16(4):161-70. PubMed ID: 5491480
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clofibrate--overreaction?].
    Viikinkoski P
    Duodecim; 1979; 95(14-15):875-7. PubMed ID: 487961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clofibrate--helpful or harmful?].
    Hartmann G; Micheli H; Mordasini R; Noseda G; Stähelin HB
    Schweiz Med Wochenschr; 1979 Aug; 109(31):1137-9. PubMed ID: 472701
    [No Abstract]   [Full Text] [Related]  

  • 10. The clofibrate trial--the lipid hypothesis retested.
    Med J Aust; 1979 Jun; 1(11):490-1. PubMed ID: 381862
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clofibrate in the primary prevention of coronary disease].
    Bjerkelund C
    Tidsskr Nor Laegeforen; 1979 Sep; 99(25):1199-1201. PubMed ID: 505440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clofibrate--facts and controversies].
    Sznajderman M
    Pol Arch Med Wewn; 1980 Feb; 63(2):101-6. PubMed ID: 7360682
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Clofibrate in prevention of ischaemic heart-disease.
    Chakrabarti R; Meade TW
    Lancet; 1975 Apr; 1(7910):799. PubMed ID: 48019
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardio-vascular disease and public health.
    Med J Aust; 1972 Apr; 1(15):725-7. PubMed ID: 5023218
    [No Abstract]   [Full Text] [Related]  

  • 16. Clofibrate and the prevention of ischaemic heart disease.
    N Z Med J; 1979 Jun; 89(637):435-6. PubMed ID: 289017
    [No Abstract]   [Full Text] [Related]  

  • 17. Serious adverse effects with clofibrate.
    N Z Med J; 1980 Oct; 92(670):315-6. PubMed ID: 6934431
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of clofibrate.
    Sirtori CR
    Lancet; 1981 Jun; 1(8234):1362. PubMed ID: 6113326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
    de Gennes JL
    Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186
    [No Abstract]   [Full Text] [Related]  

  • 20. The clofibrate saga: a retrospective commentary.
    Oliver M
    Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.